MST1/Drp1 axis mediates microglia pro-inflammatory activation following cerebral ischemia-reperfusion injury

Yao Mu1,2, Jianping Liu3, Yi Dong4

  • 1The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264000, Shandong, China.

Scientific Reports
|June 13, 2026
PubMed

Insights

The mammalian sterile 20-like kinase 1/dynamin-related protein 1 (MST1/Drp1) axis drives microglia inflammation after stroke. Inhibiting MST1 or Drp1 reduces brain injury by decreasing mitochondrial fission and pro-inflammatory responses.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Cerebral ischemia-reperfusion injury (CIRI) triggers neuroinflammation, involving microglia activation.
  • The mammalian sterile 20-like kinase 1/dynamin-related protein 1 (MST1/Drp1) pathway is implicated in cellular stress responses.

Purpose of the Study:

  • To investigate the role of the MST1/Drp1 axis in microglia pro-inflammatory activation during CIRI.
  • To determine if targeting MST1/Drp1 can mitigate brain injury.

Main Methods:

  • Established in vivo (MCAO/R in rats) and in vitro (OGD/R in BV-2 cells and primary microglia) models of CIRI.
  • Utilized MST1/Drp1 inhibitors (XMU-MP-1/Mdivi-1) and genetic manipulation (siMST1, Drp1 overexpression).
  • Assessed MST1/Drp1 expression/activation, mitochondrial morphology, microglia activation markers, cytokine release, DNA fragmentation, and neurological function.

Main Results:

  • Reperfusion/reoxygenation increased MST1 and Drp1 phosphorylation and Drp1 mitochondrial translocation, leading to excessive mitochondrial fission.
  • MST1 or Drp1 inhibition reduced p-MST1/p-Drp1(Ser616), attenuated mitochondrial fission, and suppressed microglia pro-inflammatory activation and cytokine release (TNF-α, IL-6, IL-1β).
  • Genetic knockdown of MST1 reduced p-Drp1(Ser616) and microglia activation, effects reversed by Drp1 overexpression.

Conclusions:

  • The p-MST1/p-Drp1(Ser616) axis promotes microglia pro-inflammatory activation via excessive mitochondrial fission during CIRI.
  • Inhibiting the MST1/Drp1 pathway offers a potential therapeutic strategy for mitigating cerebral injury.
  • Combined inhibition of MST1 and Drp1 demonstrated enhanced protective effects.